Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
Author Information
Author(s): Chinmay S. Marathe, Christopher K. Rayner, Karen L. Jones, Michael Horowitz
Primary Institution: University of Adelaide
Hypothesis
GLP-1 and incretin-based therapies have significant effects on gastrointestinal motility.
Conclusion
GLP-1 slows gastric emptying and has important implications for glycemic control in diabetes.
Supporting Evidence
- GLP-1 is secreted in response to food and helps regulate insulin.
- GLP-1 slows gastric emptying, which can help lower blood sugar levels after meals.
- Exenatide and liraglutide are GLP-1 analogues used in diabetes treatment.
Takeaway
GLP-1 is a hormone that helps control blood sugar by slowing down how fast food leaves the stomach, which can help people with diabetes.
Methodology
This review summarizes current knowledge of GLP-1's effects on gut motility at different concentrations and the motor actions of incretin-based therapies.
Limitations
The review does not cover the inhibitory action of GLP-1 on gastric acid secretion.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website